Dynamic Biometric Systems, Inc. Announces Integration With Laserfiche

• Press Release
• Source: Dynamic Biometric Systems, Inc.
• On 3:54 pm EST, Thursday January 8, 2009

PHOENIX, AZ--(MARKET WIRE)--Jan 8, 2009 -- Dynamic Biometric Systems, Inc. (Other OTC:DYBO.PK - News), a Nevada corporation (the "Company"), announced today that it will introduce the integration of DynaSig's Bio-Pen with the Laserfiche electronic document management system at the 2009 Laserfiche Institute Conference in Los Angeles from Jan 12-14, 2009 (www.laserfiche.com).

Related Quotes

Symbol	Price	Change
DYBO.PK	0.15	0.00

{"s" : "dybo.pk","k" : "c10,l10,p20,t10","o" : "","j" : ""}

DynaSig Corporation, a Laserfiche Professional Development Program partner, will introduce the Bio-Pen, a newly patented biometric pen device to provide secure identity authentication and signature validation in a single step. The patented Bio-Pen captures the genuine act of signing by sensing the unique biomechanics of each user's writing style to produce a self-notarizing, multi-dimensional digital representation of the user's signature. The Bio-Pen is the first of its kind to be integrated with Laserfiche for greater security and workflow productivity gains. Dr. Richard Kim, inventor of the Bio-Pen along with Greg Dutton, Managing Partner of ArcWare Solutions, will present the technology behind this unique device and DynaSig's roadmap for further integration with Laserfiche.

The Bio-Pen is the most practical and cost-effective biometric device for any size organization that wishes to ensure the privacy and the true identity of the person who created, accessed, signed, or sent a document. Laserfiche electronic document management systems (EDMS) are designed to archive scanned images, electronic documents, e-mail messages, and digital audio and video files, and automate workflows all from a single, easy-to-use interface. DynaSig chose Laserfiche to be the first EDMS platform to integrate with because of Laserfiche's longevity (since 1987), adoption (25,000 installs worldwide) and strategic focus on the three most document-intensive vertical markets: Government, Healthcare, and Financial Services.

The Bio-Pen Laserfiche integrated system is now available to the worldwide Laserfiche Value Added Reseller network through DynaSig's commercial distributor, ArcWare Solutions, in Chandler, Arizona (www.ArcWareSolutions.com). As a Laserfiche Value-Added Reseller and integrator of the Bio-Pen, ArcWare Solutions is in an excellent position to support other Laserfiche VARs and end users.

About DBSI. The Company currently trades on the Pink Sheets under the symbol DYBO. Information on the Company including current financial information is available on the Company's web site www.dynasig.com. Since 2003, the Company has developed the "Bio-Pen," a patented biometric pen and security token hardware (U.S. Patent No. 7,433,499) combined with the Dynamic Signature software, together the "DynaSig System," and Private Lock Infrastructure concept (patents pending) to provide a flexible biometric authentication methodology. This highly sophisticated system captures the unique act of signing rather than the signature image. The Company has developed multiple solutions including full electronic authentication combined with actual signature capture for both on-line and off-line applications. DynaSig software: Log Book, PDF Sign and Lock Box are used for access control and electronic document management. These applications work individually or as a suite with different features including verification of sender and recipient, access and document execution by multiple verified signers, content validation, and a permanent logbook of access. The Company's office is located at 14647 S. 50th Street, Suite 130, Phoenix, AZ 85044 and its phone number is (480) 705-9110.

Forward-Looking Statements. Certain matters discussed within this press release may be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Although the Company believes the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurances that its expectations will be attained. Such statements are inherently uncertain, and actual results and activities may differ materially from those estimated or projected. Certain factors that can affect the Company's ability to achieve its anticipated results include, among others, uncertainties inherent in the development of a new business and limited capital. Further factors affecting future performance are detailed in the Company's 10-K and 10-Q on file with the SEC and in the Company's unaudited but detailed financial information on its website. Due to changes in auditors, the Company has allowed is SEC filings to go delinquent but expects to cure such delinquency in the next several months.

     FOR MORE INFORMATION CONTACT:
      
     Michael S. Williams
     Chairman of the Board
     480-759-9400, x100